-
2 months ago | 
ophthalmologytimes.com | Martin Friedlander |Anat Loewenstein |Mohammad Rafieetary |Sheryl Stevenson
The approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) as the first and only FDA-approved treatment for macular telangiectasia type 2 (MacTel) marks a significant milestone for patients with the progressive retinal disease.1 The implantable device uses encapsulated cell therapy (ECT) technology to continuously deliver therapeutic doses of ciliary neurotrophic factor (CNTF) to the retina, helping to slow disease progression.The approval was based on the results from...
-
Nov 18, 2024 | 
optometrytimes.com | Mohammad Rafieetary |Dipl ABO |Jordana Joy
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses one of his presentations, "Suprachoroidal Delivery of Investigational ABBV-RGX-314 Gene Therapy for Diabetic Retinopathy: The Phase II ALTITUDE Study," which he gave alongside Roya Attar, OD, MBA, DHA at the AAOpt 2024 conference. Editor's note: The below transcript has been lightly edited for clarity. Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO:Hello everybody. This is Mohammad Rafieetary.
-
Nov 15, 2024 | 
optometrytimes.com | Mohammad Rafieetary |Dipl ABO |Jordana Joy
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients. Editor's note: The below transcript has been lightly edited for clarity. Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO:Hello everybody, friends and colleagues. Mohammad Rafieetary here, and I'm optometrist at the Charles Retina Institute in West Tennessee, East Arkansas, North Mississippi.
-
Nov 7, 2024 | 
healio.com | Mohammad Rafieetary |Kate Young |Heather Biele
Read more You've successfully added Retina/Vitreous in Optometry to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Nov 6, 2024 | 
healio.com | Mohammad Rafieetary |Kate Young |Heather Biele
Read more You've successfully added Retina/Vitreous in Optometry to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. INDIANAPOLIS — A single in-office treatment of ABBV-RGX-314 was well-tolerated and improved severity of diabetic retinopathy, according to 1-year study results presented at Academy 2024.
-
Jun 21, 2024 | 
optometrytimes.com | Mohammad Rafieetary |Dipl ABO |Emily Kaiser Maharjan |Jordana Joy
In this interview, Mohammad Rafieetary, OD, FAAO, discusses his American Optometric Association (AOA) lecture titled, "Through the eye of the needle," which focuses on the experiences of patients receiving eye injections for retinal diseases. The lecture is interactive, featuring a panel including Jessica Haynes, OD, FAAO, FORS, and Roya Attar, OD, MBA, FAAO.
-
Dec 18, 2023 | 
evolvemeded.com | Mark Dunbar |Mohammad Rafieetary
Upon completion of this activity, the participant should be able to: Recognize the prevalence and risk factors for retinal vein occlusion (RVO) Describe the signs, symptoms, and imaging tests that can aid in the diagnosis of RVO Investigate systematic causes of RVO Develop strategies for improved communication and collaboration with primary care practitioners and retinal specialists involved in the care of patients with RVO Summarize best practices for treating and managing patients with RVO...
-
Dec 18, 2023 | 
evolvemeded.com | Mark Dunbar |Mohammad Rafieetary
Upon completion of this activity, the participant should be able to: Recognize the prevalence and risk factors for retinal vein occlusion (RVO) Describe the signs, symptoms, and imaging tests that can aid in the diagnosis of RVO Review the differential diagnosis for RVO Investigate systematic causes of RVO Develop strategies for improved communication and collaboration with primary care practitioners and retinal specialists involved in the care of patients with RVO Summarize best practices...
-
Oct 13, 2023 | 
optometrytimes.com | Mohammad Rafieetary |Dipl ABO |Emily Kaiser Maharjan
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, met with Optometry Times to discuss his upcoming presentations on OCT, AMD imaging, and the PULSAR clinical trial and the American Academy of Optometry. This video transcript has been lightly edited for clarity. Emily Kaiser Maharjan:Hi everyone.
-
Aug 21, 2023 | 
optometrytimes.com | Mohammad Rafieetary |Dipl ABO
Until recently, when most eye care professionals encountered a patient with age-related macular degeneration (AMD), there was a true/false dilemma: Is it “wet” or not? Everything else got swept under the rug. True, we discussed lifestyle modifications, dietary supplements, self-monitoring or remote monitoring of monocular vision, and low-vision aids, but we shied away from any meaningful discussion about dry AMD.
